Computational Systems Biology Suppliers & Manufacturers

Stilla Technologies is the multiplex digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer and liquid biopsy studies, cell and gene therapies, ...

VISIA LAB is an emerging company engaged in the design, development and production of hardware and software solutions for IVD clinical laboratory diagnostics, with various fields of application, including cytodiagnostics & cytogenetics, digital and ...

Cytocast, an innovative TechBio startup located in Budapest, is at the forefront of data-driven medical technology.The company's primary focus is on integrating extensive multi-omics data with high-performance computing and advanced data science ...

Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets. This technology platform combined with the pharmacologic ...

InvivoSciences, Inc. (IVS) is a precision medicine company personalizing the drug development process by introducing patient-derived and gene-edited human samples, including 3D engineered microtissues. Our unique integration of cell & tissue ...

Evogene is a leading computational biotechnology company developing novel products for life science markets through the use of a unique Computational Predictive Biology (‘CPB’) platform. The ‘CPB’ platform has been designed for the in-silico ...

DermBiont, Inc. pioneering the world’s leading precision dermatology company developing targeted topical therapeutics that address the root cause of skin diseases. Mining our curated library of microbes to build a pipeline of products to treat ...

PhenoSys was founded in 2006 and is an R&D company based in the centre of Berlin in Germany. We engineer and market innovative technology for animal behaviour research. Our team draws on extensive expertise of electrical and mechanical engineering, ...

Periso SA. REACH (EC 1907/2006) aims to improve the protection of human health and the environment through the better and earlier identification of the intrinsic properties of chemical substances. Our mission: designing innovative technologies for ...

We are developing blood tests that detect cancer in its earliest stages so we can transform cancer into a disease that’s preventable and curable. We are developing Signal-X™, a multi-cancer platform able to detect various types of high-burden ...